Attachments
Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.
Research
Web page
Please link to the article in online versions of
your report (the URL will go live after the embargo
ends).
Journal/
conference: JAMA Dermatology
conference: JAMA Dermatology
Research:Paper
Organisation/s:
Oregon Health & Science University, USA
Funder:
The research reported in this
article was funded through the National Institute of
Arthritis and Musculoskeletal and Skin Diseases
(AR071057). The use of REDCap electronic data capture tools in this trial was supported by the
National Center for Advancing Translational
Sciences of the National Institutes of Health
(UL1TR002369). The CeraVe lotion and ointments
(options 4 and 1, respectively) were provided by
L’Oreal USA, the Vanicream lotion (option 3) was
provided by Pharmaceutical Specialties, Inc, and
the Cetaphil lotion (option 2) was provided by
Galderma Laboratories, LP. None of the emollient
companies were involved in the design,
implementation, analysis, or reporting of the
study results.